Trading halt
Filed with ASX · · 2 pages · English
On 6ix: 6ix.com/news/trading-halt-1590
The securities of Biotron Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Wednesday, 15 October 2014 or when the announcement is released to the ma
Earlier from Biotron
- Phase 2 Hepatitis C Trial Success
- BIT225 May have a broader role in limiting HIV-1 infection
- Biotron compounds tested for activity against Zika virus
- Interim HCV genotype 3 data from BIT225-008 study
- Annual Report to Shareholders
Later from Biotron
- $1.5 Million R&D Tax Rebate
- Biotron compounds demonstrate activity against Zika virus
- Zika Virus Program Update
- BIT225 Accelerates HIV-1 Virus Reduction
- $1.6 Million R&D Tax Rebate Received
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron